Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
rocilinostat (ACY-1215)
i
Other names:
ACY-1215, ACY-63, ACY1215, ACY 1215, ACY63, ACY 63
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
BC Regenacy, BMS, Regenacy
Drug class:
HDAC6 inhibitor
Related drugs:
‹
HSB-510 (0)
KA2507 (0)
ACY-241 (0)
nexturastat A (0)
HSB-510 (0)
KA2507 (0)
ACY-241 (0)
nexturastat A (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
High HDAC6 score
Solid Tumor
High HDAC6 score
Solid Tumor
ACY-1215
Sensitive: C3 – Early Trials
ACY-1215
Sensitive
:
C3
ACY-1215
Sensitive: C3 – Early Trials
ACY-1215
Sensitive
:
C3
High HDAC6 score + HR positive
HER2 Negative Breast Cancer
High HDAC6 score + HR positive
HER2 Negative Breast Cancer
ACY-1215
Sensitive: C3 – Early Trials
ACY-1215
Sensitive
:
C3
ACY-1215
Sensitive: C3 – Early Trials
ACY-1215
Sensitive
:
C3
TP53 mutation
Breast Cancer
TP53 mutation
Breast Cancer
ACY-1215
Sensitive: D – Preclinical
ACY-1215
Sensitive
:
D
ACY-1215
Sensitive: D – Preclinical
ACY-1215
Sensitive
:
D
TP53 mutation
Squamous Cell Carcinoma of Head and Neck
TP53 mutation
Squamous Cell Carcinoma of Head and Neck
AZD1775 + ACY-1215
Sensitive: D – Preclinical
AZD1775 + ACY-1215
Sensitive
:
D
AZD1775 + ACY-1215
Sensitive: D – Preclinical
AZD1775 + ACY-1215
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login